{
  "doc-9d8acfd3db5ecc25dc0c899abf9f856e": {
    "relation_pairs": [
      [
        "HM",
        "Manuscript"
      ],
      [
        "COVID-19",
        "Remdesivir"
      ],
      [
        "Drug Treatment Options",
        "Robinson J"
      ],
      [
        "Phase 1-2 Clinical Trial",
        "United Kingdom"
      ],
      [
        "Algeria",
        "China"
      ],
      [
        "Angiotensin-Converting Enzyme 2 (ACE2)",
        "SARS-CoV-2"
      ],
      [
        "Sinopharm",
        "Sinovac"
      ],
      [
        "Hamad Medical Corporation",
        "Nassiba Taib"
      ],
      [
        "BBIBP-CorV",
        "United Arab Emirates (UAE)"
      ],
      [
        "Chu CM",
        "Thorax"
      ],
      [
        "APL Bioeng",
        "Alpdagtas S"
      ],
      [
        "COVID-19",
        "Neurological Manifestations"
      ],
      [
        "Phase 1/2 Clinical Trials",
        "SARS-CoV-2 Vaccine"
      ],
      [
        "SARS-CoV-2 Variants",
        "WHO"
      ],
      [
        "Aley PK",
        "Folegatti PM"
      ],
      [
        "MAN",
        "Manuscript"
      ],
      [
        "NVX-CoV2373",
        "Novavax"
      ],
      [
        "PCR Fragment",
        "SARS-CoV-2"
      ],
      [
        "Clinical Trial",
        "rAd26 and rAd5 Vector-Based Heterologous Prime-Boost COVID-19 Vaccine"
      ],
      [
        "SARS-CoV-2",
        "Spike Glycoprotein"
      ],
      [
        "Mexico",
        "Phase 1-2 Clinical Trial"
      ],
      [
        "Phase 1-2 Clinical Trial",
        "Puerto Rico"
      ],
      [
        "rAd26-S",
        "rAd5-S"
      ],
      [
        "P.1",
        "Transmissibility"
      ],
      [
        "J Clin Microbiol",
        "PCR Melting-Temperature Assay"
      ],
      [
        "B.1.525",
        "Spike Protein Substitutions"
      ],
      [
        "SARS-CoV-2",
        "Spike Protein"
      ],
      [
        "Dina Moustafa Abo El-Ella",
        "National Center for Cancer Care and Research"
      ],
      [
        "Molnupiravir",
        "Nature Structural & Molecular Biology"
      ],
      [
        "Chan JF",
        "Yuan S"
      ],
      [
        "Northern Ireland",
        "Phase 1-2 Clinical Trial"
      ],
      [
        "Huang C",
        "Novel Coronavirus"
      ],
      [
        "MIG",
        "SARS-CoV"
      ],
      [
        "Lancet",
        "mRNA Rabies Vaccine"
      ],
      [
        "FDA",
        "REGEN-COV"
      ],
      [
        "FDA",
        "mRNA-1273"
      ],
      [
        "Paxlovid",
        "SARS-CoV-2 Variants"
      ],
      [
        "Microbiol Spectr",
        "Zelyas N"
      ],
      [
        "National Center for Cancer Care and Research",
        "Varghese Philipose Inchakalody"
      ],
      [
        "CoronaVac",
        "Sinovac Biotech Ltd"
      ],
      [
        "COVID-19 Vaccine (Vero Cell)",
        "COVID-19 Vaccine (Vero Cell) Inactivated"
      ],
      [
        "Chemiluminescent Immunoassays",
        "SARS-CoV-2"
      ],
      [
        "Colonic Cells",
        "SARS-CoV"
      ],
      [
        "B.1.525",
        "SARS-CoV-2"
      ],
      [
        "COVID-19 Vaccine",
        "Sputnik V"
      ],
      [
        "Variants of Concern",
        "WHO"
      ],
      [
        "Nested RT-PCR Assays",
        "SARS-CoV-2 VOC-alpha"
      ],
      [
        "Puvar AP",
        "Travadi T"
      ],
      [
        "Al Kaabi N",
        "BBIBP-CorV Vaccine"
      ],
      [
        "COVID-19 Vaccine",
        "DV"
      ],
      [
        "D614G",
        "N501Y"
      ],
      [
        "BNT162b2",
        "SARS-CoV-2 Spike"
      ],
      [
        "Nat Rev Microbiol",
        "Shi ZL"
      ],
      [
        "Zika Virus",
        "mRNA Vaccines"
      ],
      [
        "Oxford-AstraZeneca Vaccine",
        "Pottegård A"
      ],
      [
        "Clin Drug Investig",
        "Tocilizumab"
      ],
      [
        "Flannery B",
        "Safety"
      ],
      [
        "COVID-19",
        "REGEN-COV"
      ],
      [
        "Int J Infect Dis",
        "Rapid Screening for SARS-CoV-2 Variants"
      ],
      [
        "COVID-19",
        "mRNA-1273"
      ],
      [
        "Phase 1",
        "Phase 2"
      ],
      [
        "COVINTOC",
        "Soin AS"
      ],
      [
        "AR",
        "QF"
      ],
      [
        "B.1.617.1",
        "Spike Protein Substitutions"
      ],
      [
        "Diagnostic Methods",
        "SARS-CoV-2 Variants"
      ],
      [
        "Manuscript",
        "Shahab Uddin"
      ],
      [
        "Immuno-Assay",
        "SARS-CoV-2"
      ],
      [
        "RNA-Dependent RNA Polymerase",
        "Remdesivir"
      ],
      [
        "Brazil",
        "COVID-19 Vaccine (Vero Cell) Inactivated"
      ],
      [
        "COVID-19",
        "LAMP Assays"
      ],
      [
        "Gam-COVID-Vac",
        "SARS-CoV-2"
      ],
      [
        "Automated Western Immunoblotting",
        "SARS-CoV-2 Antibodies"
      ],
      [
        "AZD1222",
        "Antibody Dependent Cellular Cytotoxicity"
      ],
      [
        "ACE2",
        "SARS-CoV-2"
      ],
      [
        "Therapeutics",
        "Vaccines"
      ],
      [
        "Immuno-Compromised Individuals",
        "Vaccines"
      ],
      [
        "BNT162b2",
        "Memory T Cells"
      ],
      [
        "Guo J",
        "Mondal M"
      ],
      [
        "Hamad Medical Corporation",
        "University of Bern"
      ],
      [
        "Hamad Medical Corporation",
        "Mona O. Mohsen"
      ],
      [
        "AZD1222 Vaccine",
        "WHO"
      ],
      [
        "Influenza Vaccine Effectiveness Network",
        "Noah Carter"
      ],
      [
        "Covid-19 Vaccines",
        "NVX-CoV2373"
      ],
      [
        "BioNTech",
        "COVID-19 Vaccine"
      ],
      [
        "2019-new Coronavirus",
        "Remdesivir"
      ],
      [
        "COVINTOC",
        "Choudhary NS"
      ],
      [
        "B.1.617.1",
        "SARS-CoV-2"
      ],
      [
        "Oxford-AstraZeneca COVID-19 Vaccine",
        "Pottegård A"
      ],
      [
        "Ebola Vaccines",
        "Uganda"
      ],
      [
        "Morocco",
        "Sinopharm Vaccine"
      ],
      [
        "Casirivimab",
        "REGEN-COV"
      ],
      [
        "Blood Clots",
        "Oxford/AstraZeneca Vaccine"
      ],
      [
        "Giovacchini N",
        "Int J Infect Dis"
      ],
      [
        "Real-Time PCR Technology",
        "Viral Envelope"
      ],
      [
        "BNT162b2 mRNA COVID-19 Vaccine",
        "Pfizer"
      ],
      [
        "Anti-SARS-CoV-2 Antibody-Based Detection",
        "SARS-CoV-2"
      ],
      [
        "Genome Sequencing",
        "SARS-CoV-2"
      ],
      [
        "Hadi Mohamad Yassine",
        "Hamad Medical Corporation"
      ],
      [
        "Nasopharyngeal Swab",
        "SARS-CoV-2"
      ],
      [
        "Kabinger F",
        "Molnupiravir"
      ],
      [
        "FDA",
        "Tocilizumab"
      ],
      [
        "Molnupiravir",
        "RNA-Dependent RNA Polymerase"
      ],
      [
        "Manuscript",
        "SU"
      ],
      [
        "BCN-PEP-CoV2 Research Group",
        "Hydroxychloroquine"
      ],
      [
        "REMAP-CAP Trial",
        "Tocilizumab"
      ],
      [
        "La Rosa G",
        "SARS-CoV-2"
      ],
      [
        "B.1.351 Variant",
        "Remdesivir"
      ],
      [
        "Central Nervous System (CNS)",
        "MERS-CoV"
      ],
      [
        "Allplex SARS-CoV-2/FluA/FluB/– RSV Assay",
        "SARS-CoV-2 VOC-alpha"
      ],
      [
        "COVID-19 Vaccination",
        "Transplant Recipients"
      ],
      [
        "Funding",
        "Qatar National Library"
      ],
      [
        "Anti-SARS-CoV-2 Antibody",
        "IgG"
      ],
      [
        "Sputnik V Vaccine",
        "rAd26 and rAd5"
      ],
      [
        "Chimpanzee Vectors",
        "Crohn Disease Vaccine"
      ],
      [
        "Li F",
        "Nat Rev Microbiol"
      ],
      [
        "BNT162b2 mRNA COVID-19 Vaccine",
        "BioNTech"
      ],
      [
        "AZD1222 Vaccine",
        "European Countries"
      ],
      [
        "B.1.1.7",
        "NVX-CoV2373"
      ],
      [
        "C4591001 Clinical Trial Group",
        "COVID-19 Vaccine"
      ],
      [
        "Alazawi W",
        "N Engl J Med"
      ],
      [
        "COVID-19",
        "Tocilizumab"
      ],
      [
        "COVID-19 Variants",
        "Diagnostics"
      ],
      [
        "B.1.1.7",
        "Transmissibility"
      ],
      [
        "Recombinant Adenovirus Type 5",
        "SARS-CoV-2 Vaccine"
      ],
      [
        "B.1.617.2 (Delta) Variant",
        "BNT162b2 Vaccine"
      ],
      [
        "SARS-CoV-2",
        "mRNA-1273"
      ],
      [
        "SARS-CoV-2",
        "Science Translational Medicine"
      ],
      [
        "OVID-Vac",
        "SARS-CoV-2"
      ],
      [
        "Omicron Variant",
        "Real-Time PCR Technology"
      ],
      [
        "Infected Cells",
        "Macrophages"
      ],
      [
        "Recombinant Adenovirus Type 26",
        "SARS-CoV-2 Vaccine"
      ],
      [
        "BNT162b2",
        "Saei A"
      ],
      [
        "China",
        "Sinovac"
      ],
      [
        "Enzyme Linked Immunosorbent Assays (ELISA)",
        "Immuno-Assay"
      ],
      [
        "Chloroquine",
        "Hydroxychloroquine"
      ],
      [
        "COVID-19",
        "N Engl J Med"
      ],
      [
        "Anti-SARS-CoV-2 Antibody",
        "SARS-CoV-2"
      ],
      [
        "Current Diagnostic Methods",
        "Falzone L"
      ],
      [
        "Paxlovid",
        "SARS-CoV-2"
      ],
      [
        "Clinical Effectiveness Study",
        "Transplant Recipients"
      ],
      [
        "BNT162b2",
        "Phase III Clinical Trials"
      ],
      [
        "Rabies",
        "mRNA Vaccines"
      ],
      [
        "Denmark",
        "Oxford-AstraZeneca"
      ],
      [
        "COVID-19 Vaccine (Vero Cell)",
        "SARS-CoV-2 (CN2 strain)"
      ],
      [
        "No Severe Adverse Reactions",
        "Phase 1 Trials"
      ],
      [
        "ACTT-2 Study Group Members",
        "Kalil AC"
      ],
      [
        "Aluminium Hydroxide",
        "COVID-19 Vaccine (Vero Cell)"
      ],
      [
        "Baboon",
        "NevX-CoV2373 Vaccine"
      ],
      [
        "PCR-Based Tests",
        "SARS-CoV-2 Variants"
      ],
      [
        "Baricitinib",
        "Kalil AC"
      ],
      [
        "Falzone L",
        "Tsatsakis A"
      ],
      [
        "Cultivation of Viruses",
        "Tyrrell DA"
      ],
      [
        "MM",
        "Manuscript"
      ],
      [
        "Human Papillomavirus Infections",
        "Whole Virus Vaccines"
      ],
      [
        "Emergency Use Authorization",
        "Oxford/AstraZeneca Vaccine"
      ],
      [
        "Hamad Bin Khalifa University",
        "Hamad Medical Corporation"
      ],
      [
        "AA",
        "Manuscript"
      ],
      [
        "B.1.1.7 Variant",
        "BNT162b2 Vaccine"
      ],
      [
        "Manuscript",
        "Qatar National Library"
      ],
      [
        "Infected Cells",
        "NK Cells"
      ],
      [
        "Keech CMD",
        "Matrix-M Adjuvant"
      ],
      [
        "COVID-19 Vaccine (Vero Cell) Inactivated",
        "Phase II Clinical Trials"
      ],
      [
        "Multi-Target Assays",
        "SARS-CoV-2 Variants"
      ],
      [
        "Frozen Formulation",
        "Lyophilized Formulation"
      ],
      [
        "Athletics Championship",
        "Noah Carter"
      ],
      [
        "COVID-19 Vaccine (Vero Cell)",
        "Rhesus Macaca Mulatta"
      ],
      [
        "Diagnostic Methods",
        "SARS-CoV-2"
      ],
      [
        "Baculovirus-Spodoptera Frugiperda (Sf9)",
        "NVX-CoV2373"
      ],
      [
        "P.1",
        "Spike Protein Substitutions"
      ],
      [
        "CD8 T Cells",
        "mRNA Vaccines"
      ],
      [
        "Lancet",
        "rAd26 and rAd5 Vector-Based Heterologous Prime-Boost COVID-19 Vaccine"
      ],
      [
        "COVID-19",
        "Ritonavir"
      ],
      [
        "BNT162b2",
        "SARS-CoV-2"
      ],
      [
        "Manuscript",
        "SM"
      ],
      [
        "B.1.351",
        "mRNA-1273"
      ],
      [
        "COVID-19 Vaccine Tracker",
        "Oxford/AstraZeneca Vaccine"
      ],
      [
        "Imdevimab",
        "REGEN-COV"
      ],
      [
        "Inactivated Virus Vaccines",
        "Live Attenuated Virus Vaccines"
      ],
      [
        "Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines",
        "Heterologous Prime-Boost Vaccination"
      ],
      [
        "BBIBP-CorV",
        "SOTRs (Solid Organ Transplant Recipients)"
      ],
      [
        "BBIBP-CorV",
        "SARS-CoV-2"
      ],
      [
        "B.1.1.7 Variant",
        "SARS-CoV-2"
      ],
      [
        "LZ",
        "Manuscript"
      ],
      [
        "COVID-19 Vaccine (Vero Cell)",
        "Clinical Trials"
      ],
      [
        "SARS-CoV-2",
        "new variants"
      ],
      [
        "Al Kaabi N",
        "SARS-CoV-2"
      ],
      [
        "SARS-CoV-2",
        "Viral Epidemic"
      ],
      [
        "BNT162b2",
        "FDA"
      ],
      [
        "REMAP-CAP Trial",
        "Sarilumab"
      ],
      [
        "DM",
        "Manuscript"
      ],
      [
        "B.1.1.7",
        "BNT162b2"
      ],
      [
        "Spike Glycoprotein Vaccine Candidate NVX-CoV2373",
        "Tian JH"
      ],
      [
        "Coronavirus Disease 2019",
        "Guan WJ"
      ],
      [
        "Chung JR",
        "Influenza Incidence Surveillance Project"
      ],
      [
        "NVX-CoV2373",
        "Protein Subunit Vaccines"
      ],
      [
        "Baricitinib",
        "Remdesivir"
      ],
      [
        "BNT162b2",
        "Burgess JL"
      ],
      [
        "China",
        "SARS-CoV"
      ],
      [
        "SARS-CoV-2 Variants",
        "Serological Testing"
      ],
      [
        "COVID-19 Vaccination",
        "SARS-CoV-2"
      ],
      [
        "Doha",
        "Hamad Medical Corporation"
      ],
      [
        "Logunov DY",
        "rAd26 and rAd5 Vector-Based COVID-19 Vaccine"
      ],
      [
        "BBIBP-CorV",
        "Phase III Trials"
      ],
      [
        "Lancet",
        "Oxford-AstraZeneca COVID-19 Vaccine"
      ],
      [
        "Paxlovid",
        "Sheahan TP"
      ],
      [
        "Computational Approaches",
        "Emerging Variants of Concern (VOCs)"
      ],
      [
        "Protein Vaccine",
        "SARS-CoV-2"
      ],
      [
        "Remdesivir",
        "SARS-CoV-2 Variants"
      ],
      [
        "Inactivated Virus Vaccines",
        "WHO"
      ],
      [
        "Brazil",
        "Clinical Trials"
      ],
      [
        "Gam-COVID-Vac",
        "rAd5"
      ],
      [
        "COVID-19 Vaccine (Vero Cell) Inactivated",
        "WHO"
      ],
      [
        "Manuscript",
        "SD"
      ],
      [
        "COVID-19 Vaccine (Vero Cell) Inactivated",
        "Sinovac"
      ],
      [
        "Cui J",
        "Shi ZL"
      ],
      [
        "COVID-19 Vaccine",
        "SARS-CoV-2"
      ],
      [
        "Omicron Variant",
        "SARS-CoV-2"
      ],
      [
        "BNT162b2 Vaccine",
        "Health Care Personnel"
      ],
      [
        "India",
        "Tocilizumab"
      ],
      [
        "Moderna",
        "mRNA-1273 SARS-CoV-2 Vaccine"
      ],
      [
        "Chan JF",
        "Genomic Characterization"
      ],
      [
        "Algeria",
        "UAE Ministry of Health"
      ],
      [
        "CRISPR-Cas13-based diagnostics",
        "Gao D"
      ],
      [
        "Mautner L",
        "Virol J"
      ],
      [
        "Revenko H",
        "Safety"
      ],
      [
        "SARS-CoV-2",
        "SARS-CoV-2 Antigen"
      ],
      [
        "National Center for Cancer Care and Research",
        "Queenie Fernandes"
      ],
      [
        "CDC",
        "SARS-CoV-2 Variants"
      ],
      [
        "Thompson et al.",
        "mRNA-1273"
      ],
      [
        "Remap-Cap",
        "Sarilumab"
      ],
      [
        "RNA Template",
        "V-2 Mutagenesis"
      ],
      [
        "Phase-III Trial Results",
        "Sinovac Vaccine"
      ],
      [
        "COVID-19",
        "mRNA Vaccines"
      ],
      [
        "Immunogenicity",
        "Phase IV Clinical Trial"
      ],
      [
        "BNT162b2",
        "Thompson MG"
      ],
      [
        "Hu B",
        "Wang D"
      ],
      [
        "Clinical Effectiveness Study",
        "Qin CX"
      ],
      [
        "Hamad Medical Corporation",
        "Takwa Bedhiafi"
      ],
      [
        "NVX-CoV2373",
        "New England Journal of Medicine"
      ],
      [
        "ChAdOx1 nCoV-19",
        "SARS-CoV-2"
      ],
      [
        "COVID-19",
        "Wuhan"
      ],
      [
        "AZD1222 Vaccine",
        "European Medicines Agency"
      ],
      [
        "Detection of Coronaviruses",
        "Intervirology"
      ],
      [
        "Alpdagtas S",
        "Ilhan E"
      ],
      [
        "Bynoe ML",
        "Tyrrell DA"
      ],
      [
        "Antiviral Res",
        "SARS-CoV-2"
      ],
      [
        "Lambe T",
        "Rollier CS"
      ],
      [
        "COVID-19",
        "Lopinavir"
      ],
      [
        "Diagnostics",
        "SARS-CoV-2 Protein Detection"
      ],
      [
        "Gam-COVID-Vac",
        "rAd26"
      ],
      [
        "Baillie CK",
        "Mautner L"
      ],
      [
        "COVID-19 Pandemic",
        "Healthcare Workers"
      ],
      [
        "B.1.526",
        "Spike Protein Substitutions"
      ],
      [
        "Hamad General Hospital",
        "Shahab Uddin"
      ],
      [
        "COVID-19",
        "Lopinavir-Ritonavir"
      ],
      [
        "B.1.525",
        "United Kingdom/Nigeria"
      ],
      [
        "Manuscript",
        "QF"
      ],
      [
        "Automated Western Immunoblotting",
        "Eur J Clin Microbiol Infect Dis"
      ],
      [
        "AZD1222",
        "SARS-CoV-2"
      ],
      [
        "AZD1222",
        "CD4 T Cell Response"
      ],
      [
        "BBIBP-CorV Vaccine",
        "Xia S"
      ],
      [
        "SARS-CoV-2",
        "Sputnik V Vaccine"
      ],
      [
        "Membrane Glycoprotein",
        "SARS-CoV-2"
      ],
      [
        "BNT162b2",
        "Foulkes S"
      ],
      [
        "BBIBP-CorV Vaccine",
        "Zhang Y"
      ],
      [
        "B.1.526",
        "United States"
      ],
      [
        "Ng KY",
        "Tsang NNY"
      ],
      [
        "Hamad Medical Corporation",
        "Martin F. Bachmann"
      ],
      [
        "Croxen MA",
        "Zelyas N"
      ],
      [
        "Lopinavir-Ritonavir",
        "Wang Y"
      ],
      [
        "ChAdOx1 nCoV-19 Vaccine",
        "Folegatti PM"
      ],
      [
        "Algeria",
        "Sinopharm COVID-19 Vaccine"
      ],
      [
        "Infected Cells",
        "Neutrophils"
      ],
      [
        "Central Nervous System (CNS)",
        "SARS-CoV"
      ],
      [
        "COVE Study",
        "Moderna COVID-19 Vaccine Candidate"
      ],
      [
        "B.1.526",
        "SARS-CoV-2"
      ],
      [
        "Broughton JP",
        "Yu G"
      ],
      [
        "Ding Y",
        "SARS-CoV"
      ],
      [
        "mRNA Vaccines",
        "mRNA-Based Therapeutics"
      ],
      [
        "SARS-CoV-2",
        "Transmissibility"
      ],
      [
        "COVID-19",
        "Neuroinvasive Potential"
      ],
      [
        "B.1.1.7",
        "Spike Protein Substitutions"
      ],
      [
        "Infect Genet Evol",
        "Sanger-based Screening"
      ],
      [
        "Folegatti PM",
        "Lancet"
      ],
      [
        "ChAdOx1 nCoV-19 Vaccine",
        "Phase 1/2 Trial"
      ],
      [
        "Gordon CJ",
        "J Biol Chem"
      ],
      [
        "J Biological Chemistry",
        "Molnupiravir"
      ],
      [
        "Reverse Transcriptase PCR Melting-Temperature Assay",
        "SARS-CoV-2 Variants"
      ],
      [
        "ACTT-2 Study Group",
        "Kalil AC"
      ],
      [
        "COVID-19",
        "Neurologic Symptoms"
      ],
      [
        "Amino Acid Mutations",
        "SARS-CoV-2"
      ],
      [
        "BBIBP-CorV Vaccine",
        "China"
      ],
      [
        "Jiang R",
        "Phase IV Clinical Trial"
      ],
      [
        "Afsheen Raza",
        "Translational Cancer Research Facility"
      ],
      [
        "B.1.1.529",
        "Spike Protein Substitutions"
      ],
      [
        "COVID-19",
        "CRISPR-Cas13-based Diagnosis"
      ],
      [
        "Coronaviridae",
        "Tyrell and Bynoe"
      ],
      [
        "P681H",
        "SARS-CoV-2"
      ],
      [
        "Influenza A",
        "mRNA Vaccines"
      ],
      [
        "Mautner L",
        "Rapid Detection Methods"
      ],
      [
        "Authors of the Manuscript",
        "Qatar National Library"
      ],
      [
        "SARS-CoV-2",
        "mRNA Vaccines"
      ],
      [
        "AZD1222 Vaccine",
        "UK"
      ],
      [
        "Heath PT",
        "NVX-CoV2373"
      ],
      [
        "E484K",
        "SARS-CoV-2"
      ],
      [
        "SARS-CoV-2",
        "Wuhan"
      ],
      [
        "Broughton JP",
        "Deng X"
      ],
      [
        "B.1.1.7 Variant",
        "NSP12"
      ],
      [
        "Falzone L",
        "Gattuso G"
      ],
      [
        "SARS-CoV",
        "Severe Acute Respiratory Syndrome (SARS)"
      ],
      [
        "LZ",
        "QF"
      ],
      [
        "Remdesivir",
        "SARS-CoV-2"
      ],
      [
        "Ewer KJ",
        "Viral Vectors as Vaccine Platforms"
      ],
      [
        "COVID-19 Vaccine (Vero Cell) Inactivated",
        "Macaca Mulatta"
      ],
      [
        "Manuscript",
        "VP"
      ],
      [
        "Cao B",
        "Lopinavir-Ritonavir"
      ],
      [
        "Puvar AP",
        "medRxiv"
      ],
      [
        "Drug Safety",
        "Human Papillomavirus Vaccines"
      ],
      [
        "COVID-19",
        "World Health Organization"
      ],
      [
        "Pharm J",
        "Tocilizumab"
      ],
      [
        "AZD1222 Vaccine",
        "Thrombosis"
      ],
      [
        "Healthcare Workers",
        "SARS-CoV-2"
      ],
      [
        "Lund LC",
        "Pottegård A"
      ],
      [
        "COVID-19",
        "mRNA-1273 Vaccine"
      ],
      [
        "Molecular Testing",
        "SARS-CoV-2 Variants"
      ],
      [
        "Immunogenicity",
        "Safety"
      ],
      [
        "Pabbaraju K",
        "Zelyas N"
      ],
      [
        "COVID-19 Vaccine (Vero Cell)",
        "Sinovac Biotech Ltd"
      ],
      [
        "BNT162b2",
        "COVID-19"
      ],
      [
        "Next-Generation Gene Sequencing",
        "SARS-CoV-2"
      ],
      [
        "BNT162b2",
        "Solid Organ Transplant Recipients (SOTRs)"
      ],
      [
        "Omicron",
        "SARS-CoV-2"
      ],
      [
        "BBIBP-CorV",
        "Phase I Trials"
      ],
      [
        "China",
        "Sinovac Vaccine"
      ],
      [
        "Cui J",
        "Nat Rev Microbiol"
      ],
      [
        "Coppi M",
        "Giovacchini N"
      ],
      [
        "Alpdagtas S",
        "Uysal E"
      ],
      [
        "Keech CMD",
        "NVX-CoV2373"
      ],
      [
        "Chimpanzee Vectors",
        "Malaria Vaccine"
      ],
      [
        "Hamad Medical Corporation",
        "University of Oxford"
      ],
      [
        "Phase 1/2 Studies",
        "rAd26 and rAd5 Vector-Based COVID-19 Vaccine"
      ],
      [
        "IgG Titre",
        "Phase 1/2 Clinical Trials"
      ],
      [
        "ELISA",
        "SARS-CoV-2"
      ],
      [
        "Phase III Clinical Trials",
        "mRNA-1273"
      ],
      [
        "BBIBP-CorV",
        "Sinopharm"
      ],
      [
        "Enzyme Linked Immunosorbent Assays (ELISA)",
        "SARS-CoV-2"
      ],
      [
        "Breakthrough Infections",
        "Clinical Effectiveness Study"
      ],
      [
        "COVID-19 Vaccine",
        "mRNA Vaccine"
      ],
      [
        "Antibody Treatments",
        "B.1.1.529"
      ],
      [
        "ACTT-2 Study",
        "Kalil AC"
      ],
      [
        "Broughton JP",
        "Nat Biotechnol"
      ],
      [
        "COVE Study Group",
        "mRNA-1273"
      ],
      [
        "Development of Novel Vaccine Vectors",
        "Guo J"
      ],
      [
        "B.1.617.1",
        "India"
      ],
      [
        "Phase 2",
        "Phase 3"
      ],
      [
        "P.3",
        "SARS-CoV-2"
      ],
      [
        "Parikh BA",
        "Tahan S"
      ],
      [
        "Coronaviruses",
        "Perlman S"
      ],
      [
        "Martin MA",
        "VanInsberghe D"
      ],
      [
        "Oxford/AstraZeneca Vaccine",
        "Thromboembolism"
      ],
      [
        "Gam-COVID-Vac",
        "SARS-CoV-2 Vaccine"
      ],
      [
        "Brown MJ",
        "N Engl J Med"
      ],
      [
        "Acute Cerebrovascular Disease",
        "COVID-19 Pandemic"
      ],
      [
        "Breakthrough Disease",
        "Solid Organ Transplant Recipients (SOTRs)"
      ],
      [
        "SARS-CoV-2",
        "Transplant Recipients"
      ],
      [
        "Variants of Interest",
        "WHO"
      ],
      [
        "Nguyen TV",
        "Phan LT"
      ],
      [
        "International Committee on Taxonomy of Viruses",
        "SARS-CoV-2"
      ],
      [
        "AZD1222 Vaccine",
        "World Health Organization"
      ],
      [
        "SARS-CoV",
        "Severe Acute Respiratory Syndrome"
      ],
      [
        "Gu J",
        "SARS"
      ],
      [
        "BNT162b2",
        "Naleway AL"
      ],
      [
        "AZD1222",
        "CD8 T Cell Response"
      ],
      [
        "Nucleic Acid-Based Detection",
        "Real-Time PCR Technology"
      ],
      [
        "COVE Study",
        "mRNA-1273"
      ],
      [
        "Nasopharyngeal Swab",
        "Nucleic Acid-Based Detection"
      ],
      [
        "Lancet Infect Dis",
        "Tsang NNY"
      ],
      [
        "Hydroxychloroquine",
        "SARS-CoV-2"
      ],
      [
        "COVID-19",
        "SARS-CoV-2"
      ],
      [
        "Antigen Testing",
        "SARS-CoV-2 Variants"
      ],
      [
        "REMAP-CAP",
        "Tocilizumab"
      ],
      [
        "Hamad Medical Corporation",
        "Lobna Al-Zaidan"
      ],
      [
        "MERS-CoV",
        "SARS-CoV-2"
      ],
      [
        "Clinical Specimens",
        "Immuno-Assay"
      ],
      [
        "Immuno-Assay",
        "Novel Sensor and Biosensor Technologies"
      ],
      [
        "FDA",
        "Pfizer-BioNTech COVID-19 Vaccine"
      ],
      [
        "AZD1222 Vaccine",
        "Thrombocytopenia"
      ],
      [
        "Eosinophils",
        "Infected Cells"
      ],
      [
        "Emerging Variants of Concern (VOCs)",
        "Neutralizing Antibodies"
      ],
      [
        "Microarray-Based Technology",
        "SARS-CoV-2"
      ],
      [
        "Aslam S",
        "Immunogenicity Study"
      ],
      [
        "Novel Coronavirus",
        "Zhu N"
      ],
      [
        "COVID-19",
        "FDA"
      ],
      [
        "Matrix-M",
        "NVX-CoV2373"
      ],
      [
        "CoronaVac",
        "FDA"
      ],
      [
        "Manuscript",
        "NT"
      ],
      [
        "Poliomyelitis",
        "Whole Virus Vaccines"
      ],
      [
        "Molnupiravir",
        "SARS-CoV-2 Variants"
      ],
      [
        "COVID-19 Vaccines",
        "SARS-CoV-2"
      ],
      [
        "COVINTOC",
        "Tocilizumab"
      ],
      [
        "Genomic Characterization",
        "Lu R"
      ],
      [
        "Cao B",
        "N Engl J Med"
      ],
      [
        "D614G",
        "SARS-CoV-2"
      ],
      [
        "J Phys Chem Lett",
        "SARS-CoV-2"
      ],
      [
        "Respiratory Syncytial Virus Vaccine",
        "Williams K"
      ],
      [
        "BMJ",
        "Oxford-AstraZeneca"
      ],
      [
        "COVID-19",
        "Sarilumab"
      ],
      [
        "Diagnostics",
        "SARS-CoV-2"
      ],
      [
        "Computational Approaches",
        "SARS-CoV-2"
      ],
      [
        "B.1.1.7 Variant",
        "Remdesivir"
      ],
      [
        "Phase 1-2 Clinical Trial",
        "United States of America"
      ],
      [
        "BBIBP-CorV Vaccine",
        "Duan K"
      ],
      [
        "Broughton JP",
        "CRISPR-Cas12 Detection"
      ],
      [
        "Participants",
        "Phase 1 Trials"
      ],
      [
        "Influenza",
        "Whole Virus Vaccines"
      ],
      [
        "BNT162b2",
        "SIREN Study"
      ],
      [
        "Banada P",
        "SARS-CoV-2"
      ],
      [
        "Serbia",
        "Sinopharm COVID-19 Vaccine"
      ],
      [
        "Neutralizing Antibodies",
        "Phase 1/2 Clinical Trials"
      ],
      [
        "BNT162b2 Vaccine",
        "FDA"
      ],
      [
        "Falzone L",
        "Int J Mol Med"
      ],
      [
        "BBIBP-CorV",
        "UAE"
      ],
      [
        "Nucleocapsid Protein",
        "SARS-CoV-2"
      ],
      [
        "Casirivimab",
        "Imdevimab"
      ],
      [
        "NVX-CoV2373",
        "SARS-CoV-2"
      ],
      [
        "B.1.351 Variant",
        "NSP12"
      ],
      [
        "PCR Primers",
        "VOCs"
      ],
      [
        "BNT162b2 Vaccine",
        "COVID-19 mRNA Vaccines"
      ],
      [
        "COVID-19 vaccines",
        "SARS-CoV-2"
      ],
      [
        "Cynomolgus Macaque",
        "NVX-CoV2373 Vaccine"
      ],
      [
        "Jiang R",
        "Vaccine"
      ],
      [
        "Norway",
        "Oxford-AstraZeneca"
      ],
      [
        "N501Y",
        "SARS-CoV-2"
      ],
      [
        "China",
        "Serbia"
      ],
      [
        "Angiotensin-Converting Enzyme 2",
        "SARS-CoV-2"
      ],
      [
        "COVID-19",
        "Hydroxychloroquine"
      ],
      [
        "Human Coronavirus OC43",
        "Neurons"
      ],
      [
        "Phase 3 Clinical Trials",
        "SARS-CoV-2 Vaccine"
      ],
      [
        "COVID-19 Vaccine (Vero Cell) Inactivated",
        "Turkey"
      ],
      [
        "Clin Drug Investig",
        "Zhang S"
      ],
      [
        "Efficacy of SARS-CoV-2 Antiviral Drugs",
        "Remdesivir"
      ],
      [
        "ELISA Test",
        "SARS-CoV-2 Proteins"
      ],
      [
        "Participants",
        "Phase 2 Trials"
      ],
      [
        "SARS-CoV-2",
        "SARS-CoV-2 Spike Protein"
      ],
      [
        "Chimpanzee Vectors",
        "Ebola Vaccine"
      ],
      [
        "SARS-CoV",
        "SARS-CoV-2"
      ],
      [
        "Hamad Medical Corporation",
        "Maysaloun Merhi"
      ],
      [
        "NVX-CoV2373",
        "Phase 1-2 Clinical Trial"
      ],
      [
        "Argentina",
        "BBIBP-CorV"
      ],
      [
        "Mariam Ali Yousuf Al-Nesf",
        "Translational Cancer Research Facility"
      ],
      [
        "Immunogenicity Study",
        "Mekeel K"
      ],
      [
        "B.1.617.2",
        "BNT162b2"
      ],
      [
        "RNA-Dependent RNA Polymerase",
        "SARS-CoV-2"
      ],
      [
        "COVID-19 Pandemic",
        "Neurologic Symptoms"
      ],
      [
        "Phase 2 Trials",
        "Phase 3 Trials"
      ],
      [
        "SARS-CoV-2",
        "Virulence"
      ],
      [
        "Morocco",
        "Sinopharm COVID-19 Vaccine"
      ],
      [
        "SARS-CoV-2",
        "Serapian SA"
      ],
      [
        "Kashir J",
        "LAMP Assays"
      ],
      [
        "BNT162b2",
        "Polack et al."
      ],
      [
        "Nucleic Acid-Based Detection",
        "SARS-CoV-2"
      ],
      [
        "Gordon CJ",
        "Molnupiravir"
      ],
      [
        "COVID-19",
        "Randomised Clinical Trials"
      ],
      [
        "Ali Ait Hssain",
        "Translational Cancer Research Facility"
      ],
      [
        "Lipid Nanoparticles",
        "mRNA Vaccine"
      ],
      [
        "BNT162b2",
        "mRNA-1273"
      ],
      [
        "Loop-Mediated Isothermal Amplification (LAMP)",
        "SARS-CoV-2"
      ],
      [
        "B.1.621",
        "Colombia"
      ],
      [
        "QF",
        "VP"
      ],
      [
        "REMAP-CAP",
        "Sarilumab"
      ],
      [
        "NVX-CoV2373",
        "Nonhuman Primate Models"
      ],
      [
        "Human Coronavirus 229E",
        "Neurotropism"
      ],
      [
        "Medullary Neurons",
        "SARS-CoV-2"
      ],
      [
        "ACTT-2 Study Group Members",
        "Mehta AK"
      ],
      [
        "AZD1222",
        "Neutralizing Antibodies"
      ],
      [
        "Disclosure Statement",
        "QF"
      ],
      [
        "NVX-CoV2373",
        "T Cell Response"
      ],
      [
        "Zika",
        "mRNA Vaccines"
      ],
      [
        "B.1.351 Variant",
        "BNT162b2 Vaccine"
      ],
      [
        "Therapeutic Strategies",
        "Virus"
      ],
      [
        "Chimpanzee Vectors",
        "HIV Vaccine"
      ],
      [
        "B.1.351",
        "Spike Protein Substitutions"
      ],
      [
        "JAMA",
        "Wang D"
      ],
      [
        "COVID-19 Vaccine",
        "Lancet"
      ],
      [
        "Greek Alphabet",
        "WHO"
      ],
      [
        "N Engl J Med",
        "Phan LT"
      ],
      [
        "ACTT-2 Study",
        "Mehta AK"
      ],
      [
        "BNT162b2 Vaccine",
        "India Variant (B.1.617.2)"
      ],
      [
        "So HC",
        "Tsang NNY"
      ],
      [
        "CRISPR",
        "SARS-CoV-2"
      ],
      [
        "Lancet",
        "rAd26 and rAd5"
      ],
      [
        "Lancet",
        "Russia"
      ],
      [
        "J Clin Microbiol",
        "Tahan S"
      ],
      [
        "Droit L",
        "Tahan S"
      ],
      [
        "La Rosa G",
        "Water Res"
      ],
      [
        "COVID-19",
        "UAE Ministry of Health"
      ],
      [
        "Hamad Medical Corporation",
        "Said Dermime"
      ],
      [
        "Hubei Province",
        "Wuhan"
      ],
      [
        "Remdesivir",
        "SARS-CoV-2 Polymerase"
      ],
      [
        "C.37",
        "Peru"
      ],
      [
        "Manuscript",
        "Said Dermime"
      ],
      [
        "Herold HM",
        "Mautner L"
      ],
      [
        "J Chem Inf Model",
        "SARS-CoV-2"
      ],
      [
        "Chloroquine",
        "SARS-CoV-2"
      ],
      [
        "COVID-19",
        "Public Health Emergency"
      ],
      [
        "Gorbalenya AE",
        "Severe Acute Respiratory Syndrome"
      ],
      [
        "BNT162b2",
        "Lopez Bernal J"
      ],
      [
        "Hamad Medical Corporation",
        "Sarra Mestiri"
      ],
      [
        "CRISPR-Cas13-based Diagnosis",
        "J Med Virol"
      ],
      [
        "Molnupiravir",
        "SARS-CoV-2"
      ],
      [
        "Takwa Bedhiafi",
        "Translational Cancer Research Facility"
      ],
      [
        "CAPTURE Study",
        "Emerging Variants of Concern (VOCs)"
      ],
      [
        "Omicron Variant",
        "PCR Primers"
      ],
      [
        "Marchetti F",
        "SARS-CoV-2"
      ],
      [
        "NVX-CoV2373",
        "United Kingdom"
      ],
      [
        "Ewer KJ",
        "Folegatti PM"
      ],
      [
        "L452R",
        "SARS-CoV-2"
      ],
      [
        "Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)",
        "SARS-CoV-2"
      ],
      [
        "J Med Virol",
        "SARS-CoV"
      ],
      [
        "PCR Melting Temperature Assays",
        "SARS-CoV-2"
      ],
      [
        "Koelle K",
        "Martin MA"
      ],
      [
        "COVID-19",
        "Chloroquine"
      ],
      [
        "Adler E",
        "Immunogenicity Study"
      ],
      [
        "Gam-COVID-Vac",
        "Phase 1/2 Clinical Trials"
      ],
      [
        "138 Hospitalized Patients",
        "Wang D"
      ],
      [
        "BNT162b2",
        "Hall VJ"
      ],
      [
        "MOM",
        "Manuscript"
      ],
      [
        "Acute Respiratory Distress Syndromes",
        "SARS-CoV-2"
      ],
      [
        "Ambrose CS",
        "Influenza Incidence Surveillance Project"
      ],
      [
        "Immunogenicity",
        "SARS-CoV-2 Variants"
      ],
      [
        "E154K",
        "G142D"
      ],
      [
        "C.37",
        "SARS-CoV-2"
      ],
      [
        "Phase I Clinical Trial",
        "mRNA-1273 Vaccine"
      ],
      [
        "SARS-CoV-2",
        "Triveri A"
      ],
      [
        "Clinical Effectiveness Study",
        "Immunogenicity"
      ],
      [
        "B Cell Response",
        "NVX-CoV2373"
      ],
      [
        "Antibodies",
        "SARS-CoV-2"
      ],
      [
        "RNA-Dependent RNA Polymerase (RdRP)",
        "Remdesivir"
      ],
      [
        "Remdesivir Triphosphate",
        "SARS-CoV-2"
      ],
      [
        "Clinical Trials",
        "Turkey"
      ],
      [
        "Neutralizing Antibodies",
        "Solid Organ Transplant Recipients (SOTRs)"
      ],
      [
        "BBIBP-CorV",
        "Bahrain"
      ],
      [
        "SARS-CoV-2",
        "Severity"
      ],
      [
        "Manuscript",
        "TB"
      ],
      [
        "COVINTOC",
        "Kumar K"
      ],
      [
        "AR",
        "Manuscript"
      ],
      [
        "Andrews N",
        "BNT162b2"
      ],
      [
        "B.1.617.2",
        "Spike Protein Substitutions"
      ],
      [
        "Chan JF",
        "Lancet"
      ],
      [
        "Baricitinib",
        "COVID-19"
      ],
      [
        "COVID-19 Vaccine (Vero Cell) Inactivated",
        "Phase I Clinical Trial"
      ],
      [
        "Immunochromatographic Assays",
        "SARS-CoV-2"
      ],
      [
        "Rapid Screening for SARS-CoV-2 Variants",
        "Water Research"
      ],
      [
        "Manuscript",
        "Q. Fernandes"
      ],
      [
        "P.3",
        "Philippines"
      ],
      [
        "COVID-19 Pandemic",
        "SARS-CoV-2"
      ],
      [
        "AZD1222 Vaccine",
        "Clinical Trials"
      ],
      [
        "Aiezza N",
        "Giovacchini N"
      ],
      [
        "NVX-CoV2373",
        "Northern Ireland"
      ],
      [
        "BNT162b2 Vaccine",
        "COVID-19"
      ],
      [
        "Said Dermime",
        "Translational Cancer Research Facility"
      ],
      [
        "COVID-19",
        "Reports of Suspected Adverse Reaction"
      ],
      [
        "COVID-19 Variants",
        "SARS-CoV-2"
      ],
      [
        "Anti-SARS-CoV-2 Antibody",
        "IgM"
      ],
      [
        "COVID-19 Candidate Vaccines",
        "World Health Organization"
      ],
      [
        "COVID-19 mRNA Vaccines",
        "mRNA-1273 Vaccine"
      ],
      [
        "Central Nervous System (CNS)",
        "SARS-CoV-2"
      ],
      [
        "B.1.621",
        "SARS-CoV-2"
      ],
      [
        "Remap-Cap",
        "Tocilizumab"
      ],
      [
        "BBIBP-CorV",
        "Phase II Trials"
      ],
      [
        "Kanoni S",
        "N Engl J Med"
      ],
      [
        "COVID-19 Pandemic",
        "FDA"
      ],
      [
        "COVID-19 Vaccine (Vero Cell) Inactivated",
        "Two-Dose Immunization Schedule"
      ],
      [
        "Central Nervous System",
        "SARS-CoV-2"
      ],
      [
        "Nucleocapsid",
        "Real-Time PCR Technology"
      ],
      [
        "NHS Guidance",
        "Remark-Cap"
      ],
      [
        "Immunofluorescent Assays",
        "SARS-CoV-2"
      ],
      [
        "CD4 T Cells",
        "mRNA Vaccines"
      ],
      [
        "Chemiluminescence Assays",
        "SARS-CoV-2"
      ],
      [
        "D614G",
        "P681H"
      ],
      [
        "SARS-CoV-2",
        "SARS-CoV-2 Variants of Concern (VOCs)"
      ],
      [
        "ACTT-2 Study",
        "Patterson TF"
      ],
      [
        "Magro G",
        "Virus Research"
      ],
      [
        "Dina Moustafa Abo El-Ella",
        "Translational Cancer Research Facility"
      ],
      [
        "FDA",
        "Remdesivir"
      ],
      [
        "COVID-19 Vaccine (Vero Cell) Inactivated",
        "Hypersensitivity"
      ],
      [
        "Interleukin-6 Receptor Antagonists",
        "Tocilizumab"
      ],
      [
        "MB",
        "Manuscript"
      ],
      [
        "BNT162b2",
        "Neutralizing Antibodies"
      ],
      [
        "Argentina",
        "Sinopharm"
      ],
      [
        "Comorbidities",
        "NVX-CoV2373"
      ],
      [
        "Flannery B",
        "US Influenza Vaccine Effectiveness Network"
      ],
      [
        "COVE Study",
        "Moderna COVID-19 Vaccine"
      ],
      [
        "ACE2",
        "SARS-CoV"
      ],
      [
        "SARS-CoV-2",
        "Vaccines"
      ],
      [
        "B.1.351",
        "Severity"
      ],
      [
        "Cynomolgus Macaque",
        "NVX-CoV2373"
      ],
      [
        "RBD Region",
        "SARS-CoV-2"
      ],
      [
        "Oxford-AstraZeneca COVID-19 Vaccine",
        "Thromboembolism"
      ],
      [
        "Anywaine Z",
        "Ebola Vaccines"
      ],
      [
        "LAMP",
        "SARS-CoV-2"
      ],
      [
        "ChAdOx1 nCoV-19 Vaccine",
        "SARS-CoV-2"
      ],
      [
        "Chaudhari AM",
        "Puvar AP"
      ]
    ],
    "count": 603,
    "create_time": 1761791341,
    "update_time": 1761791341,
    "_id": "doc-9d8acfd3db5ecc25dc0c899abf9f856e"
  }
}